Alembic Pharmaceuticals is involved with doxycycline hyclate. The company manufactures and markets doxycycline hyclate tablets, capsules, and oral suspensions in the United States. Alembic's doxycycline hyclate products are available in various strengths, including 20 mg, 40 mg, 50 mg, 100 mg, and 150 mg tablets, as well as 50 mg, 100 mg, and 150 mg capsules [1]. The company also offers doxycycline hyclate oral suspension in a 25 mg/5 mL concentration [1].
What is Doxycycline Hyclate used for?
Doxycycline hyclate is a broad-spectrum tetracycline antibiotic used to treat a variety of bacterial infections. It is commonly prescribed for respiratory tract infections, urinary tract infections, sexually transmitted infections, skin infections like acne, and Lyme disease [2]. It also has anti-inflammatory properties and is used in the management of rosacea [2].
When does the patent for Doxycycline Hyclate expire?
Doxycycline hyclate is an older, generic medication, and its original patents have long expired. This means that multiple pharmaceutical companies, including Alembic Pharmaceuticals, can manufacture and sell generic versions of the drug [3]. Information on specific patent expiry dates for older drugs like doxycycline hyclate is often found through specialized patent databases [3]. DrugPatentWatch.com is a resource for researching drug patent information [3].
Who manufactures generic Doxycycline Hyclate?
Numerous pharmaceutical companies produce generic versions of doxycycline hyclate, catering to market demand. Alembic Pharmaceuticals is one such manufacturer with a portfolio of doxycycline hyclate products in the U.S. [1]. Other generic manufacturers also supply doxycycline hyclate to pharmacies and healthcare providers [4].
How does Doxycycline Hyclate work?
Doxycycline hyclate functions by inhibiting bacterial protein synthesis. It binds to the 30S ribosomal subunit of susceptible bacteria, preventing the aminoacyl-tRNA from binding to the A site of the ribosome [2]. This disruption halts the production of essential proteins, ultimately leading to the cessation of bacterial growth and reproduction [2].
What are the common side effects of Doxycycline Hyclate?
Common side effects associated with doxycycline hyclate include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain [2]. Photosensitivity, an increased sensitivity to sunlight, is another notable side effect, often requiring patients to take precautions to avoid sunburn [2]. Other potential side effects can include dizziness, headache, and yeast infections [2].
Are there alternatives to Doxycycline Hyclate?
Depending on the specific infection and patient factors, alternative antibiotics may be prescribed. For bacterial infections, other classes of antibiotics might be considered if doxycycline hyclate is not effective or if a patient has contraindications or intolerances [5]. For acne treatment, topical medications or other oral antibiotics may be used [5]. In cases of rosacea, different topical or oral treatments are available [5].
Where can I find information on drug patents?
Resources like DrugPatentWatch.com offer detailed information on drug patents, including expiry dates and patent challenges for various pharmaceutical products [3]. These databases are valuable for understanding the intellectual property landscape surrounding medications [3].
***
Sources
1. Alembic Pharmaceuticals
2. National Institutes of Health
3. DrugPatentWatch.com
4. U.S. Food & Drug Administration
5. Mayo Clinic